Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000426956

Medchemexpress LLC Reltecimod TFA | 1447799-33-8 | ≥98% | 1037.19 | 25 MG
SDP

Supplier:  Medchemexpress LLC 25MGHYP1698B

Encompass_Preferred

Reltecimod TFA is a T cell-specific surface glycoprotein CD28 (TP44) antagonist. It demonstrates good resistance to various bacterial infections, bacterial exotoxins and endotoxins, and ionizing radiation. Reltecimod TFA modulates the inflammatory response by targeting and attenuating the critical CD28/B7-2 costimulatory pathway without inhibiting it. It may be used to study necrotizing soft tissue infections (NSTIs).

  • T cell-specific surface glycoprotein CD28 (TP44) antagonist
  • Good resistance to different bacterial infections, bacterial exotoxins and endotoxins, and ionizing radiation
  • Modulates inflammatory response by attenuating the CD28/B7-2 costimulatory pathway
  • May be utilized to study necrotizing soft tissue infections (NSTIs)
  • Increases survival rate of mice harboring several bacterial infections (at 1.25-5 mg/kg; iv)

Catalog No. 50-004-26956


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.